ANDA 208487, held by Ingenus Pharms LLC. Carboplatin.
As of Nov 15, 2026, ANDA 208487 (Carboplatin), held by Ingenus Pharms LLC, was first approved by FDA on Apr 26, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 26, 2017 | Original application | Approved | None posted |
| Carboplatin50MG/5ML (10MG/ML) · injectable;intravenous | Carboplatin | Discontinued |
| Carboplatin150MG/15ML (10MG/ML) · injectable;intravenous | Carboplatin | Discontinued |
| Carboplatin450MG/45ML (10MG/ML) · injectable;intravenous | Carboplatin | Discontinued |
| Carboplatin600MG/60ML (10MG/ML) · injectable;intravenous | Carboplatin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
